Relieving migraine pain: Sorting through the options

Cleveland Clinic Journal of Medicine

Volumn 70, Issue 1, 2003, Pages 8-28

  Mannix, Lisa K ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALMOTRIPTAN; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIMIGRAINE AGENT; ATENOLOL; CAPTOPRIL; CORTICOSTEROID; COTRIMOXAZOLE; DIHYDROERGOTAMINE; ERGOTAMINE; GRISEOFULVIN; HISTAMINE H2 RECEPTOR ANTAGONIST; KETOROLAC; METOPROLOL; NARATRIPTAN; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; PHENOTHIAZINE DERIVATIVE; PLACEBO; PRAZOSIN; RESERPINE; RIZATRIPTAN; SUMATRIPTAN SUCCINATE; UNINDEXED DRUG; VASODILATOR AGENT; ZOLMITRIPTAN;

ANALGESIA; BATH; CLUSTER HEADACHE; COMORBIDITY; CONSERVATIVE TREATMENT; CONTROLLED STUDY; CRYOTHERAPY; DIETARY INTAKE; DIFFERENTIAL DIAGNOSIS; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG HALF LIFE; DRUG WITHDRAWAL; ENVIRONMENTAL EXPOSURE; FATIGUE; GASTROINTESTINAL DISEASE; HEADACHE; HORMONE ACTION; HUMAN; HYPERTHERMIC THERAPY; LEISURE; LIFESTYLE; MASSAGE; MEDICAL DECISION MAKING; MEDICAL DOCUMENTATION; MIGRAINE; NAUSEA AND VOMITING; PARESTHESIA; PATIENT ATTITUDE; PATIENT COUNSELING; PATIENT REFERRAL; PHOTOPHOBIA; PRESCRIPTION; REVIEW; SLEEP; SOMNOLENCE; SYMPTOM; TENSION HEADACHE; THORAX PAIN; TREATMENT FAILURE; TREATMENT OUTCOME; VERTIGO; VISUAL DISORDER;

EID: 0037239407     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.70.1.8     Document Type: Review

References (51)

1. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1998; 8(suppl 7):1-96.
2. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: Data from the American Migraine Study II. Headache 2001; 41:646-657.
3. Cunningham SM. Migraine: Helping clients choose treatment and identify triggers. Br J Nursing 1999; 8:1515-1523.
4. Dubose CD, Cutlip AC, Cutlip WD. Migraine and other headaches: An approach to diagnosis and classification. Am Fam Physician 1995; 51:1498-1509.
5. Diamond S. Tension-type headache. Clin Cornerstone 1999; 1:33-44.
6. Ryan RE. Headache diagnosis. Clin Cornerstone 1999; 1:11-18.
7. Silberstein SD, Lipton RB. Chronic daily headache. Curr Opin Neurol 2000; 13:277-283.
8. Lewis TA, Solomon GD. Advances in migraine management. Cleve Clin J Med 1995; 62:148-155.
9. Cady RK. Diagnosis and treatment of migraine. Clin Cornerstone 1999; 1:21-32.
10. Centonze V, Polito BM, Cassiano MA, et al. Patient education and migraine: A pilot study. Funct Neurol 1998, 13:117-123.
11. Hamel E. Current concepts of migraine pathophysiology. Can J Clin Pharmacol 1999; 6(suppl A):9A-14A.
12. Hargreaves RJ, Shepheard SL. Pathophysiology of migraine: New insights. Can J Neurol Sci 1999; 26(suppl 3):S12-S19.
13. Weiller C, May A, Limmroth V, et al. Brain stem activation in spontaneous human migraine attacks. Nat Med 1995; 1:658-660.
14. Marcus DA. Establishing a standard of speed for assessing the efficacy of the serotonin 1B/1D agonists (triptans). Arch Neurol 2001; 58:1056-1058.
15. Ramadan NM, Silberstein SD, Freitag FG, Gilbert TT, Frishberg BM. Evidence-based guidelines for migraine headache in the primary care setting: Pharmacological management for prevention of migraine. Available at www.aan.com/professionals/practice/pdfs/gl0090.pdf. Accessed September 14, 2001.
16. Bartleson JD. Treatment of migraine headaches. Mayo Clin Proc 1999; 74:702-708.
17. Matchar DB, Young WB, Rosenberg JH, et al. Evidence-based guidelines for migraine headache in the primary care setting: pharmacologic management of acute attacks. Available at www.aan.com/professionals/practice/pdfs/gl0087.pdf.
18. Dahlöf C. How to assess patient preference of migraine treatments. Cephalalgia 1999; 19(suppl 24):2-6.
19. Lipton RB, Stewart WF. Acute migraine therapy: Do doctors understand what patients with migraine want from therapy? Headache 1999; 39(suppl 2):S20-S26.
20. Cady RK, Lipton RB, Hall C, et al. Treatment of mild headache in disabled migraine sufferers: Results of the Spectrum study. Headache 2000; 40:792-797.
21. Sheftell FD. Role and impact of over-the-counter medications in the management of headache. Neurol Clin 1997; 15:187-198.
22. Pfaffenrath V, Scherzer S. Analgesics and NSAIDs in the treatment of the acute migraine attack. Cephalalgia 1995; 15(suppl 15):14-20.
23. Lipton RB, Stewart WF, Ryan RE, et al. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain. Three double-blind, randomized, placebo-controlled trials. Arch Neurol 1998; 55:210-217.
24. Diener HC, Kaube H, Limmroth V. A practical guide to the management and prevention of migraine. Drugs 1998; 56:811-824.
25. Tfelt-Hansen P, Saxena PR, Dahlöf C, et al. Ergotamine in the acute treatment of migraine. A review and European consensus. Brain 2000; 123:9-18.
26. Gawel MJ, Worthington I, Maggisano A. A systematic review of the use of triptans in acute migraine. Can J Neurol Sci 2001; 28:30-41.
27. Imitrex injection. Physicians' desk reference. Montvale, NJ: Medical Economics Co., Inc.; 2000:1195-1199.
28. Imitrex tablets. Physicians' desk reference. Montvale, NJ: Medical Economics Co., Inc.; 2000:1204-1208.
29. Imitrex nasal spray. Physicians' desk reference. Montvale, NJ: Medical Economics Co., Inc.; 2000:1199-1204.
30. Zomig tablets. Physicians' desk reference. Montvale, NJ: Medical Economics Co., Inc.; 2000:587-590.
31. Amerge tablets. Physicians' desk reference. Montvale, NJ: Medical Economics Co., Inc.; 2000:1148-1151.
32. Maxalt tablets. Physicians' desk reference. Montvale, NJ: Medical Economics Co., Inc.; 2000:1822-1826.
33. Axert tablets. Prescribing information. Available at www.axert.com. Accessed July 6, 2001.
34. Ryan RE Jr. Patient treatment preferences and the 5-HT 1B/1D agonists. Arch Intern Med 2001; 161:2545-2553.
35. Cutler N, Mushet GR, Davis R, Clements B, Witcher L. Oral sumatriptan for the acute treatment of migraine: Evaluation of three dosage strengths. Neurology 1995; 45(suppl 7):S5-S9.
36. Spencer CM, Gunasekara NS, Hills C. Zolmitriptan. A review of its use in migraine. Drugs 1999; 58:347-374.
37. Ahrens SP, Farmer MV, Williams DL, et al. Efficacy and safety of rizatriptan wafer for the acute treatment of migraine. Cephalgia 1999; 19:525-530.
38. Salonen R. Drug comparisons: Why are they so difficult? Cephalalgia 2000; 20(suppl 2):25-32.
39. Gallagher RM, Dennish G, Spierings ELH, Chitra R. A comparative trial of zolmitriptan and sumatriptan for the acute oral treatment of migraine. Headache 2000; 40:119-128.
40. Goldstein J, Ryan R, Jiang K, et al. Crossover comparison of rizatriptan 5 mg and 10 mg vs sumatriptan 25 mg and 50 mg in migraine. Headache 1998; 38:737-747.
41. Tfelt-Hansen P, Teall J, Rodriguez F, et al. Oral rizatriptan vs oral sumatriptan: A direct comparative study in the acute treatment of migraine. Headache 1998; 38:748-755.
42. Spierings EL, Gomez-Mancilla B, Grosz DE, et al. Oral almotriptan vs oral sumatriptan in the abortive treatment of migraine. A double-blind, randomized, parallel-group, optimum-dose comparison. Arch Neurol 2001; 58:944-950.
43. Tfelt-Hansen P, De Vries P, Saxena PR. Triptans in migraine. A comparative review of pharmacology, pharmacokinetics and efficacy. Drugs 2000; 60:1259-1287.
44. Bomhof M, Paz J, Legg N, et al. Comparison of rizatriptan 1 mg vs naratriptan 2.5 mg in migraine. Eur Neurol 1999; 42:173-179.
45. Mathew NT, Kailasam J, Gentry P, Chernyshev O. Treatment of nonresponders to oral sumatriptan with zolmitriptan and rizatriptan: A comparative open trial. Headache 2000; 40:464-465.
46. Moore KL, Noble SL. Drug treatment of migraine. Part 1. Acute therapy and drug-rebound headache. Am Fam Physician 1997; 56:2039-2048.
47. Kaniecki RG. Mixing sumatriptan: A prospective study of stratified care using multiple formulations. Headache 2000; 41:862-866.
48. Silberstein SD, Goadsby PJ, Lipton RB. Management of migraine: An algorithmic approach. Neurology 2000; 55(suppl 2):S46-S52.
49. Kelly A-M. Migraine: Pharmacotherapy in the emergency department. West J Med 2001; 173:189-193.
50. Cady RK, Farmer K, Wilson MJ. When to refer and what to expect. Available at www.primarycarenet.org. Accessed September 17, 2001.
51. Kaniecki RG. Diagnostic issues in migraine. Curr Pain Headache Rep 2001; 5:183-188.